Hypertension, Vol 9, 504-512, Copyright © 1987 by American Heart Association
EL Schiffrin and J St-Louis
We have previously found that vascular receptors for atrial natriuretic
peptide (ANP) in the rat are down-regulated by volume expansion. For this
reason vascular ANP receptor density and affinity were examined in a model
of volume-expanded hypertension, the deoxycorticosterone acetate
(DOCA)-salt hypertensive rat. The density of mesenteric vascular ANP
binding sites was decreased in DOCA-salt hypertensive rats from a control
value in uninephrectomized rats of 203 +/- 25 fmol/mg protein to 60 +/- 13
fmol/mg protein (p less than 0.01). The sensitivity of
norepinephrine-precontracted aorta to ANP was significantly reduced in
DOCA-salt hypertensive rats (p less than 0.001). DOCA-salt hypertensive
rats infused intravenously for 4 days with ANP, 100 to 300 ng/hr, did not
experience a lowering of blood pressure, in contrast to the significant
reduction in blood pressure seen in two-kidney, one clip Goldblatt
hypertensive rats similarly infused. In the latter there was no natriuretic
response to ANP, while in the DOCA-salt hypertensive rats natriuresis
occurred without lowering of blood pressure. In the DOCA-salt hypertensive
rats plasma ANP concentration was increased to 68 +/- 8 fmol/ml from 10 +/-
1 fmol/ml in uninephrectomized rats. In conclusion, raised ANP
concentration in plasma of volume-expanded hypertensive rats (DOCA-salt
hypertension) may result in decreased density of ANP vascular receptors.
These results suggest that a decrement in the number of ANP receptors may
be a cause of decreased sensitivity of vascular responses to ANP in vitro
and resistance to the blood pressure-lowering action of ANP in vivo.
ARTICLES
Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats
This article has been cited by other articles:
![]() |
J. Marcil, J. de Champlain, and M. B Anand-Srivastava Overexpression of Gi-proteins precedes the development of DOCA-salt-induced hypertension: relationship with adenylyl cyclase Cardiovasc Res, August 1, 1998; 39(2): 492 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshimoto, M. Naruse, A. Tanabe, K. Naruse, T. Seki, T. Imaki, T. Muraki, Y. Matsuda, and H. Demura Potentiation of Natriuretic Peptide Action by the {beta}-Adrenergic Blocker Carvedilol in Hypertensive Rats: A New Antihypertensive Mechanism Endocrinology, January 1, 1998; 139(1): 81 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nuglozeh, M. Mbikay, D. J. Stewart, and L. Legault Gene expression of natriuretic peptide receptors in rats with DOCA-salt hypertension Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1427 - C1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-A. Haefliger, E. Castillo, G. Waeber, G. E. Bergonzelli, J.-F. Aubert, E. Sutter, P. Nicod, B. Waeber, and P. Meda Hypertension Increases Connexin43 in a Tissue-Specific Manner Circulation, February 18, 1997; 95(4): 1007 - 1014. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1987 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |